Control-Group 发表于 2025-3-25 03:30:05

http://reply.papertrans.cn/16/1585/158490/158490_21.png

CUMB 发表于 2025-3-25 10:59:20

An Overview of Brevinin Superfamily: Structure, Function and Clinical Perspectiveshe end, we discuss various means of modification of biologic properties of Brevinins, either by chemical modifications or by amino acid substitution and sequence rearrangements. In this context, also other unique properties of Brevinins are briefly mentioned. Finally, we discuss the future of the Br

bioavailability 发表于 2025-3-25 15:27:06

http://reply.papertrans.cn/16/1585/158490/158490_23.png

biopsy 发表于 2025-3-25 17:54:12

,Ausführungslänge der Schnecken,xenografted hepatoma and melanoma mouse models PTD4-apoptin protein entered both cancer and normal cells, but only killed cancer cells. Combinatorial treatment of PTD4-apoptin with various (chemo)therapeutic compounds revealed an additive or even synergistic effect, reducing the side effects of the

寻找 发表于 2025-3-25 20:44:29

Bestimmung der Arbeitsprofile der Schnecke,isms. Although several explanations for the cancer-specificity of E4orf4-induced toxicity have been proposed, a better grasp of the mechanisms responsible for E4orf4-induced cell death is required to elucidate the differential sensitivity of normal and cancer cells to E4orf4.

Atheroma 发表于 2025-3-26 02:58:25

https://doi.org/10.1007/978-3-642-91513-0Moreover, MDA-7/IL-24 has proven efficacious in a Phase I/II clinical trial in humans with multiple advanced cancers. As research in the field progresses, we will unravel more of the functions of MDA-7/IL-24 and define novel ways to utilize MDA-7/IL-24 in the treatment of cancer.

disparage 发表于 2025-3-26 06:05:25

http://reply.papertrans.cn/16/1585/158490/158490_27.png

Habituate 发表于 2025-3-26 09:31:38

http://reply.papertrans.cn/16/1585/158490/158490_28.png

MIME 发表于 2025-3-26 13:17:51

http://reply.papertrans.cn/16/1585/158490/158490_29.png

时代错误 发表于 2025-3-26 19:35:36

http://reply.papertrans.cn/16/1585/158490/158490_30.png
页: 1 2 [3] 4 5 6
查看完整版本: Titlebook: Anticancer Genes; Stefan Grimm Book 2014 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer-Verlag Londo